About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
31 03, 2025

Dogecoin Price Prediction: Can DOGE Avoid a $0.10 Retest and Rally Above $0.30?

By |2025-03-31T08:44:29+02:00March 31, 2025|Crypto News, News|0 Comments

Dogecoin (DOGE) has been facing mounting pressure in recent weeks, with analysts debating whether the meme coin can reverse its downtrend and push toward the $0.30 mark.

Market indicators suggest a battle between bullish optimism and bearish sentiment, leaving investors questioning the next move for the popular cryptocurrency.

According to crypto analyst Moein Haddadian, DOGE has broken out of a descending trendline, a technical signal that suggests selling pressure may be weakening. However, key resistance levels remain a hurdle. For Dogecoin to establish a strong recovery, it must first surpass the $0.25 price point.

Dogecoin (DOGE) was trading at around $0.17 at press time. Source: Brave New Coin

“A confirmed breakout above this level could solidify bullish dominance and drive the price toward $0.30,” Haddadian explained.

Key Resistance and Support Levels

Despite a glimmer of bullish momentum, Dogecoin is still hovering near critical support levels. The $0.16 level is now a critical line of support. If it continues to serve as support, analysts expect a consolidation above $0.205 before rallying toward $0.30–$0.334. A decline below $0.16, however, would be bad for DOGE, with potential falls to $0.122 or even $0.113.

Dogecoin Price Prediction: Can DOGE Avoid a alt=

Dogecoin (DOGE) price is holding above $0.17 support and could reverse for a fresh bullish rally from this level. Source: Ace1trades via X

The noted cryptocurrency analyst, Ali Martinez, has also opined on the chances of DOGE. Martinez pointed out the primary $0.21 resistance level. Martinez’s SuperTrend indicator study indicates that closing above the resistance level would finalize the start of a new bullish cycle in DOGE. A breakdown, though, would lead to further sideways movement or even a downturn.

Market Sentiment: Will Dogecoin See a Reversal?

The broader cryptocurrency market has remained volatile, and Dogecoin is no exception. Analysts remain divided over its short-term trajectory. Some believe the coin is on the verge of a huge breakout, while others caution that DOGE could go back to $0.10 if selling pressure rises.

Market Sentiment: Will Dogecoin See a Reversal

Dogecoin ($DOGE) has flashed a TD Sequential buy signal on the weekly chart, hinting at a potential reversal. Source: Ali Martinez via X

Historical data shows that Dogecoin has followed cyclical patterns, mirroring previous market activity that led to massive rallies. Crypto trader DogeCapital recently pointed out that DOGE’s current price action resembles past fractals that preceded explosive growth phases. If history repeats itself, Dogecoin could be on track for a significant upswing.

Rising anxiety among Dogecoin (DOGE) holders could signal incoming volatility

Rising anxiety among Dogecoin (DOGE) holders could signal incoming volatility. Source: Ali Martinez via X

However, market analyst Henry warns that the coin is still at a crossroads. “Dogecoin has shown signs of strength, but unless it can sustain momentum above key resistance levels, we could see another leg down before a potential rally,” he noted.

Long-Term Outlook: Can DOGE Hit $1?

While short-term price action remains uncertain, some analysts hold a bullish long-term outlook for Dogecoin. Predictions suggest that if DOGE can establish sustained bullish momentum, it could eventually target $1 or higher.

Long-Term Outlook: Can DOGE Hit $1?

Dogecoin price could hit the $1 milestone following the survival of $0.17 support. Source: ProfitProphet911 on TradingView

For now, the DOGE price prediction hinges on its ability to break past crucial resistance levels and maintain bullish support. The meme coin’s strong community backing and growing adoption may provide tailwinds, but the battle between buyers and sellers remains fierce.

Final Thoughts

Dogecoin investors are at a critical juncture. If DOGE manages to hold above key support and break past $0.25, the stage could be set for a rally above $0.30. However, failure to do so may bring further declines, potentially testing the $0.10 level. As always, market participants should monitor resistance levels, investor sentiment, and broader market trends before making any decisions.

Source link

31 03, 2025

Gold price attacks current resistance – Forecast today

By |2025-03-31T06:52:31+02:00March 31, 2025|Forex News, News|0 Comments


Gold price failed to maintain early gains and bounced lower, settling on a mild decline, after the current resistance of $3090 held its ground, with the price gathering positive momentum that could help it breach that resistance, while also venting off overbought saturation in the Stochastic, with negative signals emerging from it.

 

It comes amid the dominance of the main upward trend as the price trades alongside the secondary short-term trend line, with positive support due to trading above the 50-candle SMA.

To get our more detailed analysis and 100% accurate signals provided by Best Trading Signal, subscribe to Economies.com VIP Club through the link below!





Source link

31 03, 2025

GBP/JPY Forecast: Triangle Breakout Signals Potential Bullish Rally to 2007 Highs

By |2025-03-31T06:49:38+02:00March 31, 2025|Forex News, News|0 Comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.

Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.

It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.

Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2007-2025 – Fusion Media Limited. All Rights Reserved.



Source link

31 03, 2025

Can natural supplements backfire? Review explains how and why

By |2025-03-31T06:46:32+02:00March 31, 2025|Dietary Supplements News, News|0 Comments


A new review uncovers how common natural supplements can both protect and endanger health, depending on dose, duration, and delivery—and points to next-gen technologies as the key to unlocking their full therapeutic power.

Review: The double-edged sword of nutraceuticals: comprehensive review of protective agents and their hidden risks. Image Credit: Light Stock / Shutterstock

In a recent review in the journal Frontiers in Nutrition, researchers collated and summarized more than 120 publications to elucidate the dual therapeutic and toxicological effects of nutraceuticals. The review highlights the proceeds of preclinical and clinical studies focusing on curcumin (CUR), piperine (PPR), resveratrol (RSV), and quercetin (QUE) between 2015 and 2024.

Study findings reveal that while all evaluated nutraceuticals provide medically beneficial protective and therapeutic effects, each comes with its own side effects, particularly at higher dosages, highlighting the need for scientifically sound guidelines aimed at managing interactions and enhancing the benefits of nutraceuticals without subjecting patients to their adverse effects. The review further suggests innovations such as nanoencapsulation and AI-guided delivery systems that could help achieve these goals.

Background

Nutraceuticals are foods or food derivatives that serve not only as sources of essential nutrition but also as pharmacological benefits. They include dietary supplements, herbal medicines, and probiotics. While the term “nutraceutical” (“nutrition” and “pharmaceutical”) is relatively recent, the concept dates back hundreds or even thousands of years.

Nutraceuticals are gaining popularity worldwide due to their organic origins and lower side effects compared to conventional synthetic drugs. However, a growing body of literature suggests that when taken out of context (without a prescription) or when consumed at higher dosages or in specific populations, bioactive nutraceuticals may pose medical challenges. This necessitates a scientifically sound understanding of the pros and cons of nutraceuticals, along with a case-specific, balanced consumption plan to maximize the pharmacological benefits of these supplements with minimal risk.

“The growing interest in nutraceuticals stems from their potential to address chronic diseases, such as cardiovascular disorders, neurodegenerative conditions, and metabolic syndromes, which are often linked to oxidative stress and inflammation.”

The positive benefits of nutraceuticals are well documented. Unfortunately, given their relative novelty, the literature remains relatively scarce on the long-term effects of nutraceuticals, particularly their toxicity upon prolonged use, bioavailability, and interactions with conventional medical interventions. The review also emphasizes the lack of globally harmonized regulatory frameworks governing nutraceutical purity, labeling, and safety claims.

About the Review

The present review aims to collate and summarize existing scientific knowledge on nutraceuticals to elucidate two main topics: the mechanisms determining the therapeutic and toxicological effects of nutraceuticals and recommendations for the safe and effective use of these supplements. The review aims to guide clinicians, policymakers, researchers, and consumers in determining when and how to use nutraceuticals effectively, thereby maximizing their benefits while minimizing potential drawbacks.

The review focuses on four widely used nutraceuticals:  Resveratrol (RSV), a polyphenolic compound found in grapes and grape products;  Curcumin (CUR), a bioactive obtained from turmeric (Curcuma longa); Piperine (PPR), obtained from black pepper; and Quercetin (QUE), a flavonoid found in several fruits and vegetables.

Publications of interest were obtained from three online scientific repositories (Scopus, PubMed, and Web of Science) using a custom keyword search. Title, abstract, and full-text screening shortlisted ~120 publications for inclusion, ensuring only studies exhibiting clinical relevance, methodological rigor, and mechanistic insights were included.

Resveratrol

RSV is gaining increasing scientific interest due to its wide-ranging therapeutic benefits, including cardiovascular, metabolic, neurological, pro-apoptotic, and anti-inflammatory. The bioactive notably reduces oxidative stress, improves lipid metabolism, and reduces blood pressure. It has even been clinically validated to enhance cognitive function and delay Alzheimer’s disease (AD) progression. However, RSV exhibits hormetic effects—protective at low doses but harmful at high doses—with studies demonstrating toxicity at elevated concentrations, including renal impairment and thyroid dysfunction. Chronobiological differences in RSV administration have also been observed, with some evidence suggesting time-of-day may influence lipid peroxidation and drug metabolism.

Curcumin

CUR is arguably the best-studied antioxidant and anti-inflammatory in this review, routinely used to manage diabetes, arthritis, and cardiovascular diseases (CVDs). It also targets several oncological pathways and exhibits significant neuroprotective benefits. CUR’s interference with CVD drugs (e.g., amlodipine) occurs via modulation of CYP3A4 and P-glycoprotein (P-gp) pathways, underscoring the importance of complete health profile assessments before its use. Emerging evidence also notes potential impacts on thyroid hormone levels and reproductive function in animal models, particularly at high doses or via nanoparticle delivery systems.

Piperine

PPR is often used as an adjunct and adjuvant, known for its anti-inflammatory, anti-oxidative stress, neuroprotective, and bioavailability-enhancing properties. Preclinical studies report reproductive toxicity in rats at doses exceeding 10 mg/kg, alongside risks of enhancing side effects of drugs like carbamazepine and warfarin. Emerging evidence also links prolonged high-dose PPR to impaired cognitive performance in animal models, highlighting the importance of understanding and educating the target patient before its prolonged consumption. Recent data also indicate tissue-level alterations and potential organ-specific toxicity in rodent models receiving higher doses.

“A hallmark of PPR is its ability to augment the bioavailability of drugs and nutrients. By inhibiting drug-metabolizing enzymes (e.g., cytochrome P450, UDP-glucuronosyltransferase) and enhancing intestinal absorption, PPR significantly inhibits P-glycoprotein (P-gp). It enhances the efficacy of co-administered compounds, such as CUR and RSV, positioning it as a critical adjunct in nutraceutical formulations.”

Quercetin

QUE is often obtained naturally, derived from the consumption of onions and apples. Its hallmark effects include free radical neutralization, oxidative stress mitigation, and enhancement of cellular integrity, making it a nutraceutical hailed as a potential treatment for cancer, cardiovascular disease (CVD), and aging. While QUE synergizes with certain chemotherapeutics (e.g., methotrexate) to enhance anti-inflammatory effects, it may also interfere with drugs like cyclosporine. High-dose QUE supplements have been linked to pro-oxidant activity and organ damage in preclinical studies. The aglycone form found in supplements exhibits greater bioavailability but also a higher likelihood of interacting with drug-metabolizing enzymes and transporters.

Summary and Future Directions

This review provides extensive details on the pros and cons of four of the most popular available nutraceuticals, highlighting their therapeutic and pharmacological benefits while cautioning against potential dose- and interaction-dependent side effects.

It further suggests emerging technologies, such as nanoencapsulation, to improve targeted delivery and bioavailability of these nutraceuticals, reducing off-target toxicity and ensuring that these bioactives reach their target organs or tissues, thereby maximizing their benefits and mitigating their costs. Additional innovations discussed include in silico molecular docking to predict drug-target interactions, nutrigenomic tools for personalizing interventions, and the Nutraceutical Interaction Risk Score (NIRS) to stratify patients by potential toxicity.

“…while nutraceuticals represent a valuable tool in promoting health and preventing disease, their full potential can only be realized through rigorous scientific research, personalized dosing strategies, and a comprehensive understanding of both their benefits and potential risks. The investigational integration of nanotechnology and smart materials has emerged as a transformative approach to enhance the efficacy and safety of nutraceuticals.”



Source link

31 03, 2025

Is $2 Possible In March? Analysts Tout Mutuum Finance (MUTM) To Trump ADA This Year

By |2025-03-31T06:43:36+02:00March 31, 2025|Crypto News, News|0 Comments

Cardano (ADA) rose 8% during the period between March 23 and March 25, attempting to break above the $0.76 resistance level for the third time in two weeks. Optimism from founder Charles Hoskinson’s campaign to promote network scalability and decentralization of governance hasn’t helped the token price remain buoyed, either, with ADA still 35% off its March 3 peak of $1.18. Speculations abound around partnerships with Trump-linked crypto ventures, but analysts wonder if ADA’s DeFi ecosystem can provide enough momentum to recover $1, much less $2. Instead, Mutuum Finance (MUTM) is quickly becoming the go-to choice for investors seeking high upside potential for their cryptocurrency, whose presale is now in Phase 4 and a launch price 140% higher than presale.

Cardano’s Uphill Battle

And Cardano’s more recent price action hangs partly on political events. Donald Trump’s March 3 social media endorsement of ADA caused a rally, but later policy movements excluded altcoins from the U.S. Digital Asset reserves. Now, all eyes are on the upcoming DC Blockchain Summit 2025, at which Trump Jr. and Hoskinson will take the same stage. When looking ahead to what investors can expect in the future, some claim to look forward to partnerships with Trump-backed companies such as World Liberty Financial, whereas other critics describe these ventures as “pay-to-play” and not actually rooted in DeFi.

Cardano’s layer-2 solution Hydra has recorded 1 million transactions per second in tests, and its eUTXO model claims base-layer transaction failures of zero—compared to Solana’s 40% failure rate. But DeFi adoption has been slow, leading protocol Indigo offers 28% yields on stablecoins but the returns which are paid in native tokens do not help the appeal. ADA’s ascent to $2, analysts say, hinges on demonstrable bumps in user activity and institutional inflows, neither of which have yet come to fruition.

Mutuum Finance Gains Momentum

While ADA suffers over the uncertainty of their future projects, it has little else to concern itself with compared to Mutuum Finance (MUTM), which has attracted 7,400 investors who have so far contributed $5.7 million to its presale. Phase 4 tokens are priced at $0.025, with a 20% increase to $0.03 coming in Phase 5. With the listing price set at $0.06, that’s already secured 140% profits for pre-release buyers, and with post-launch projections of $3 mean it’ll be a 14,900% jump from this stage.

Demand is driven by the project’s lending model. Users lock assets such as ETH or stablecoins into the platform, in exchange for interest-bearing mtTokens, which grow in value over time and can be traded on a range of DeFi platforms. MUTM tokens are continuously in demand from a buy-and-distribute mechanism where platform revenue is redirected to buy back MUTM tokens. In addition, overcollateralized loans and something that resembles peer to peer lending allows a greatly reduced systemic risk, appealing to conservative investors.

Security and Incentives

Mutuum Finance’s smart contract audit with Certik is almost done, with results to be published soon through official channels. The giveaway of 100,000 dollars to presale players, coupled with all this transparency, further cultivates confidence. Ten investors will take home $10,000 each as Phase 3 winds down fueling the FOMO even more.

But as Cardano wrestles with execution of its technical strengths into market prevalence, Mutuum Finance (MUTM) brings together functionality and investor attraction. Its computed tokenomics and low presale entry point are concrete advantages over the speculative political gusts afflicting ADA. With Phase 4 in, gaining tokens for $0.025 becomes a narrow window phase which could be deciding for anyone ready for an exponential growth.

Time To Act

Cardano’s $2 target depends on the whims of some other forces altogether: regulatory changes, partnership announcements and DeFi adoption. That differs from Mutuum Finance (MUTM), which sets measurable goals, locking in presale profits and reporting a target of $3 post launch that aligns with analyst consensus. It is worth noting that Certik verification is in the final stage of assessment, with Phase 4 live, meaning to delay risk missing out on the lowest price available. In a turbulent crypto market, investors demanding clarity are turning to MUTM’s defined path to growth.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://www.mutuum.finance/
Linktree: https://linktr.ee/mutuumfinance

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Source link

31 03, 2025

XAU/USD rises to near record high below $3,100 amid global uncertainty

By |2025-03-31T04:51:36+02:00March 31, 2025|Forex News, News|0 Comments


  • Gold price climbs to near $3,090 in Monday’s early Asian session. 
  • Escalating global trade tensions and economic uncertainties boost the safe-haven flows, supporting Gold price. 
  • Traders brace for the US March ISM Manufacturing PMI data, which is due later on Tuesday. 

The Gold price (XAU/USD) gains momentum to around $3,090 during the early Asian session on Monday. The precious metal maintains its uptrend near a record high amid fears of a global trade war triggered by US President Donald Trump’s latest tariffs.

Trump last week announced a 25% tariff on imported cars and light trucks set to take effect on April 3. This measure comes on top of a flat 25% tariff on steel and aluminum and Trump’s impending reciprocal tariff announcement on Wednesday. The ongoing fears related to trade wars and global economic uncertainty boost the yellow metal, a traditional safe-haven asset. 

Data released by the Bureau of Economic Analysis on Friday showed that the US core Personal Consumption Expenditures (PCE) Price Index rose 0.4% MoM in February, compared to 0.3% in January. This figure came in hotter than the expectation of 0.3%. On an annual basis, the core PCE jumped 2.8% in February versus 2.7% prior (revised from 2.6%). 

The report suggested sticky inflation in the US economy. Nonetheless, Trump’s aggressive trade policy raises concerns that the economy may fall into stagflation or even recession. This, in turn, undermines the Greenback and lifts the USD-denominated commodity price. 

Traders will keep an eye on the US ISM Manufacturing Purchasing Managers Index (PMI) for March, which is due later on Tuesday. If the report shows a stronger-than-expected outcome, this could underpin the US Dollar (USD) and cap the upside for the Gold price. 

Gold FAQs

Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.

 



Source link

31 03, 2025

Green Tea Group’s Application for Listing in HK Filed by CSRC; THREE SQUIRRELS/ CIG Plan to Issue H-shrs in HK

By |2025-03-31T04:45:39+02:00March 31, 2025|Dietary Supplements News, News|0 Comments


For sharing news, please enter the email address of you and the receiver, then press SEND button.

Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com

Green Tea Group’s Application for Listing in HK Filed by CSRC; THREE SQUIRRELS/ CIG Plan to Issue H-shrs in HK

Green Tea Group, a Chinese restaurant group, received a notification of overseas offering and listing filing from the China Securities Regulatory Commission (CSRC) for its applicat…

The window will close in 5 seconds



Source link

31 03, 2025

Ripple XRP Price Prediction for April: Can Thursday’s SEC Meeting Bring ETF and SWIFT Deal?

By |2025-03-31T04:42:54+02:00March 31, 2025|Crypto News, News|0 Comments

xrp-usd

Skerdian Meta••2 min read

Register now to be able to add articles to your reading list.

” aria-hidden=”true”>


Share in Facebook

“>

On Thursday SEC will hold a closed meeting, which might propel XRP higher if they finally pass the Ripple case, increasing SWIFT adapting as well.

Ripple Update: Analyst Forecasts Volatility For XRP In Anticipation of SEC Meeting
Ripple Update: Analyst Forecasts Volatility For XRP In Anticipation of SEC Meeting

Early March Rally on Donald Trump’s Crypto Reserve Comments

Ripple (XRP) started March with a surge, briefly reaching $2.98 after U.S. President Donald Trump mentioned Ripple and other cryptocurrencies while discussing the National Crypto Reserve. However, the rally was short-lived as Trump later clarified that XRP, Solana, and Cardano (ADA) were not included in the reserve. This clarification triggered a sharp selloff, bringing XRP back down below $2, nearing $1.90. Despite the decline, the $2 level held firm as a key support zone, preventing a deeper drop.

XRP Chart Daily – SEC Settlement Boosts Optimism but Fails to Sustain Gains

Later in the month, XRP saw another spike, climbing 10% on positive news related to the long-standing SEC lawsuit. Ripple CEO Brad Garlinghouse officially announced that the case had been settled, declaring that the legal battle was finally over. Despite this, XRP investors struggled to maintain the momentum as broader market sentiment turned bearish. By Saturday, XRP/USD had dropped to $2.07, reflecting ongoing uncertainty in the crypto space, however the $2 level held as support again.

Ripple also confirmed that it would no longer pursue its cross-appeal against the SEC. As part of the settlement, the agency will retain $50 million of the original $125 million fine imposed by Judge Torres, refunding the remaining amount to Ripple. While this marks a step toward regulatory clarity, XRP’s price reaction has been muted, raising concerns among investors.

April 3 SEC Meeting and ETF Speculation

This week Agency will hold a meeting on Thursday which might turn out to be a crucial moment for Ripple and its investors. This discussion could provide clarity on the approval of XRP-spot ETFs and offer potential regulatory relief for the cryptocurrency. If the outcome is positive, it may pave the way for Ripple’s expansion in the U.S. financial markets and attract greater institutional investment.

At the same time, Ripple’s integration with traditional financial networks is gaining traction. Reports suggest that over 10,000 banks have successfully tested Ripple on SWIFT’s payment system, signaling growing interest in its international transaction capabilities. Earlier this month, speculation surfaced that SWIFT was nearing an agreement with Ripple to incorporate XRP into its global payment infrastructure, however it remains to be seen how it will progress, particularly with the SEC case.

Future Scenarios: Can XRP Break New Highs?

The future price action of XRP will largely depend on regulatory decisions and institutional adoption. If the SEC withdraws its appeal, finalizes a favorable settlement, and approves XRP-spot ETFs, Ripple’s price could climb beyond the record high of $3.40 which was placed on January, with the possibility of reaching $5 in the mid-term.

However, if uncertainty lingers—whether due to Ripple reversing its decision on the cross-appeal, a failed SWIFT partnership, or the SEC rejecting XRP-spot ETFs—the cryptocurrency may struggle to hold its current levels and could drop below $2 and $1.90, which would open the door for $1.

With critical developments unfolding, the next move for XRP will likely be determined by the SEC’s decision on April 3 and broader sentiment in the financial markets.

Ripple XRP Lie Chart

XRP/USD

Skerdian Meta

Lead Analyst

Skerdian Meta Lead Analyst.
Skerdian is a professional Forex trader and a market analyst. He has been actively engaged in market analysis for the past 11 years. Before becoming our head analyst, Skerdian served as a trader and market analyst in Saxo Bank’s local branch, Aksioner. Skerdian specialized in experimenting with developing models and hands-on trading. Skerdian has a masters degree in finance and investment.



Source link

31 03, 2025

Treasure NFT Freezes Cash Withdrawals for Many; A Major Red Flag for Investors?

By |2025-03-31T03:05:22+02:00March 31, 2025|News, NFT News|0 Comments


Treasure NFT, a platform that claims to generate high returns through AI-driven NFT trading, has restricted withdrawals for many users, leading to growing concerns about its legitimacy. While some investors are successfully withdrawing their funds, others are facing delays, frozen accounts, or outright denials, fuelling speculation that the platform may be experiencing liquidity issues or operating as a Ponzi scheme.

Reports from users suggest that Treasure NFT may be selectively allowing withdrawals to maintain the illusion of legitimacy. Some investors, especially early adopters or those bringing in fresh referrals, received their funds, while others have encountered excuses, technical issues, or extended delays. This pattern is often seen in financial scams, where payouts are initially processed to build trust before withdrawals become increasingly difficult.

Company Response to Withdrawal Issues

In response to growing concerns, Treasure NFT issued an official notice stating:

“The company’s financial department is temporarily adjusting the financial system today. To comply with local financial regulatory audits and ensure user fund security, the company has decided to extend the withdrawal processing time from 96 hours to 168 hours, effective immediately. Once the audit is completed, we will restore the original withdrawal time, and all financial orders will be processed 100%.”

Treasure NFT Freezes Cash Withdrawals for Many; A Major Red Flag for Investors?

The company has assured users that all pending transactions will be processed once the audit is complete. However, many investors are suspicious, suspecting that the delay is a ploy to avoid mass withdrawals before the inevitable collapse.

Treasure NFT developed as a platform guaranteeing daily returns of 4.3% to 6.8%, which are much greater than conventional investment returns. It also employs a multi-level referral system in which users are incentivised to bring in new investors, a strategy typically associated with Ponzi schemes.

Financial experts have previously cautioned that platforms with such large returns and referral-based incentives may struggle to maintain payments when new investments decline.

Treasure NFT operates as a pyramid scheme, relying on new investor referrals rather than a sustainable business model. With withdrawal restrictions and selective payments, concerns are rising that the platform is on the verge of collapse.  A large number of Pakistanis have invested substantial amounts into Treasure NFT, lured by the promise of quick and massive returns. If the platform fails to resume normal operations, it could leave thousands of investors facing substantial financial losses.



Source link

31 03, 2025

Can Bulls Defend $125, or Is a $58 Drop Incoming?

By |2025-03-31T02:42:10+02:00March 31, 2025|Crypto News, News|0 Comments

Key Insights:

  • Solana’s key support at $125 remains crucial, a breakdown could trigger a drop to $58.
  • A $140 surge could liquidate $69M in shorts, fueling a potential short squeeze.
  • With bearish momentum rising, SOL’s derivatives market sees declining open interest.

Solana price is at a crucial level, with $125 acting as strong support. A breakdown below this level could push Solana toward $58 as bearish momentum intensifies. However, if Solana surges to $140, it could trigger a short squeeze, liquidating $69 million in shorts and fueling further gains.

Solana Price Faces Bearish Pressure Below Key Support

Solana price is struggling to maintain stability above the critical $125 level. Crypto analyst, Ali Martinez noted that a failure to hold this support could result in a sharp drop toward $58. The top altcoin’s price is currently facing bearish pressure, with declining open interest in Solana’s derivatives market signaling reduced trader confidence.

Source: Ali Martinez/X

On-chain data shows weakening buy pressure, with traders adopting a cautious stance. The decline in Solana price open interest suggests fewer long positions, making it easier for bears to push the price lower. If the selling pressure continues, a breakdown below $125 could trigger a significant liquidation event, accelerating losses.

Short Squeeze Potential as Solana Price Approaches $140

Despite the bearish outlook, Solana price has a chance to regain bullish momentum. Ali Martinez highlighted that if Solana rises toward $140, it could liquidate $69 million in short positions. This could lead to a short squeeze, forcing investors to cover their positions and pushing the top altcoin’s price higher.

sol price
Source: Ali Martinez, X

A short squeeze happens when traders betting against an asset are forced to buy back at higher prices, increasing demand. If Solana price surpasses $140, it could gain further momentum, invalidating the bearish scenario. Strong buyer interest at this level could push Solana past key resistance zones, signaling renewed bullish strength.

Solana’s Derivatives Market Signals Caution

Solana’s derivatives market data reflects uncertainty among traders, with open interest declining. Lower open interest indicates that people are closing out positions instead of opening them. This indicates that the buyers and sellers of this market are anticipating a clearer signal before they can open new long or short positions in the Solana price trend.

sol price chart
Source: Coinglass

Liquidation data also bear a similar sentiment, account of which results in a lesser number of long positions being opened aggressively. An important level that may have been of interest to traders is $125, as its break means deeper losses.

Solana Price Outlook Hinges on Key Levels

Meanwhile, Coinvo’s chart further highlighted Solana’s key support zone between $115 and $130. This area has been held multiple times and has effectively acted as a strong demand level. SOL is currently testing this zone after a steep correction from its April 2024 high. Bulls must hold this level to avoid the loss of further ground.

A breakdown at $115 will lead to Solana price dropping 22% of its value to settle at $90. Further bearish pressure may pull SOL as low as $58, a previous support area. However, the high-lows pattern also gives a series of lower highs, which indicates diminishing bullish pressure or momentum.

Disclaimer

In this article, the views and opinions stated by the author or any people named are for informational purposes only, and they don’t establish the investment, financial, or any other advice. Trading or investing in cryptocurrency assets comes with a risk of financial loss.

Source link

Go to Top